Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $307000.0 for Q3 2025.

• On a quarterly basis, Operating Leases fell 85.01% year-over-year to $307000.0 in Q3 2025; TTM through Sep 2025 was $307000.0, a 85.01% decrease from a year earlier, with the FY2024 full-year figure at $1.6 million, down 49.58% from the prior year.
• Operating Leases slipped to $307000.0 in Q3 2025 per CRBP's latest filing, from $761000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $7.9 million in Q1 2021 and bottomed at $307000.0 in Q3 2025.
• The 5-year median for Operating Leases is $4.0 million (2023), against an average of $3.9 million.
• Across the five-year window, Operating Leases changed 0.0% in 2021 and tumbled 85.01% in 2025, its largest moves.
• Year by year, Operating Leases stood at $6.0 million in 2021, then retreated by 21.5% to $4.7 million in 2022, then tumbled by 30.72% to $3.2 million in 2023, then sank by 49.58% to $1.6 million in 2024, then tumbled by 81.2% to $307000.0 in 2025.
• Per Business Quant, the three latest CRBP Operating Leases figures stand at $307000.0 (Q3 2025), $761000.0 (Q2 2025), and $1.2 million (Q1 2025).